#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Immune thrombocytopenia Oesophageal squamous cell carcinoma stage III Paraneoplastic neurological syndrome Malignant oligodendroglioma Immune-mediated enterocolitis Endometrial adenocarcinoma Adrenocortical carcinoma Undifferentiated sarcoma Mitochondrial myopathy Juvenile idiopathic arthritis Chronic myeloid leukaemia Parkinson's disease B-cell small lymphocytic lymphoma refractory Alagille syndrome Becker's muscular dystrophy More trials…

    Learn about Rare Diseases

    Ewing’s sarcoma recurrent – Diagnostics Haemophilia B without inhibitors – Basic Information Alport’s syndrome – Trials in Disease Ehlers-Danlos syndrome – Diagnostics Synovial sarcoma recurrent Ewing’s sarcoma recurrent – Basic Information Basal cell naevus syndrome – Life with Disease Rhabdomyosarcoma – Treatment Prolymphocytic leukaemia Vascular malformation – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Blu-222 Lorazepam Narsoplimab Wt1/Il15/Il15Ra Mrna Dc Mirtazapine Fluorouracil Filgotinib Al8326 Calcium Folinate Pentahydrate Gskvx000000008866 Oseltamivir Amlodipine Citalopram Hydrochloride Trehalose Dihydrate (Ph.eur.) Diroximel Fumarate Tapderimotide 7-Ethyl-10-Hydroxycamptothecin Bezafibrate Theophylline Ficlatuzumab More therapies…

    Learn about Your Condition

    Cardiac disorder Anaemia of chronic disease Laryngeal cancer stage II Dystonia Premature baby Lung transplant rejection Hyperparathyroidism secondary Nasal sinus cancer Dermatomyositis Colorectal cancer stage III Vulvovaginal candidiasis Lymphocyte adoptive therapy Infantile apnoea Hypocalcaemia Fontan procedure More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study Comparing Vincristine, Actinomycin-D, and Doxorubicin with Vincristine, Carboplatin, and Etoposide for Stage IV Childhood Kidney Cancer Patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Nephroblastoma
    Investigated Drugs:
    • Dactinomycin
    • Doxorubicin Hydrochloride
    • Etoposide
    Austria Belgium Czechia Denmark France Germany +5

  • Study on Tranexamic Acid and Sodium Chloride to Reduce Bleeding in Gastric Bypass Surgery for Patients with Severe Obesity

    Recruiting

    3 1 1
    Investigated Diseases:
    • Metabolic surgery
    • Obesity
    Investigated Drugs:
    • Tranexamic Acid
    • Sodium Chloride
    The Netherlands

  • Study on Propranolol and Pembrolizumab for Patients with Advanced Angiosarcoma and Undifferentiated Pleomorphic Sarcoma

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Angiosarcoma
    • Malignant fibrous histiocytoma
    Investigated Drugs:
    • Propranolol Hydrochloride
    • Pembrolizumab
    Denmark Norway Sweden

  • Study on the Effects of Intranasal Oxytocin on Learning in Youth with Autism Spectrum Disorder

    Recruiting

    2 1 1
    Investigated Diseases:
    • Autism spectrum disorder
    Investigated Drugs:
    • Oxytocin Synthetic
    • Oxytocin
    • Sodium Chloride
    Norway

  • Study on Capsaicin for Finger Pain in Digital Osteoarthritis Patients

    Recruiting

    3 1 1
    Investigated Drugs:
    • Capsaicin
    France

  • Study on the Effect of Post-Surgery Chemotherapy with Irinotecan and Drug Combination for Patients with Colorectal Cancer and Liver Metastases

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Calcium Levofolinate
    • Methylprednisolone
    • Calcium Folinate
    France
Previous Page
1 … 488 489 490 491 492 … 1,653
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!